Explore

Rapid Read Rapid Read
Glucosamine Supplement Linked to Increased Dementia Risk in New Study

Glucosamine Supplement Linked to Increased Dementia Risk in New Study

Recent research conducted by neuroscientists at the University of Florida has identified a potential link between the use of glucosamine, a common supplement for joint pain, and an increased risk of progressing from mild cognitive impairment to Alzheimer's disease. The study, published in Nature Metabolism, utilized a large retrospective analysis of patient records and advanced imaging technology to explore this association. The findings suggest that glucosamine use is associated with a 25% higher likelihood of progression to dementia and a similar increase in mortality risk among patients with Alzheimer's disease and related dementias (ADRD). The research highlights a metabolic process involving protein and sugar-tagging pathways as a potential target for intervention in Alzheimer's disease.
Rapid Read Rapid Read
Research Links Glucosamine Supplement to Increased Dementia Risk

Research Links Glucosamine Supplement to Increased Dementia Risk

A study conducted by neuroscientists at the University of Florida has found a potential link between the use of glucosamine, a common supplement for joint pain, and an increased risk of progressing from mild cognitive impairment to Alzheimer's disease. The research, published in Nature Metabolism, involved a retrospective analysis of patient records and advanced imaging technology. The study revealed that glucosamine use was associated with a 25% higher likelihood of progression to dementia among patients with mild cognitive impairment. Additionally, glucosamine was linked to a 25% increase in mortality risk among patients with Alzheimer's disease and related dementias. The researchers suggest that altered metabolism, particularly an overactive protein and sugar-tagging pathway, may contribute to Alzheimer's progression.
Rapid Read Rapid Read
University of Florida Study Links Glucosamine to Accelerated Dementia Progression

University of Florida Study Links Glucosamine to Accelerated Dementia Progression

Researchers at the University of Florida have discovered a potential link between glucosamine, a common supplement for joint pain, and an increased risk of progressing from mild cognitive impairment to Alzheimer's disease. The study, published in Nature Metabolism, involved a retrospective analysis of patient records and advanced imaging technology. The findings suggest that glucosamine use is associated with a 25% higher likelihood of dementia progression and a similar increase in mortality risk among Alzheimer's patients. The research highlights a metabolic process involving protein and sugar-tagging pathways as a potential target for intervention. The study's results are preliminary and require further validation through human clinical trials.
Rapid Read Rapid Read
Research Links Glucosamine Supplement to Accelerated Alzheimer's Progression

Research Links Glucosamine Supplement to Accelerated Alzheimer's Progression

A new study from the University of Florida suggests that glucosamine, a supplement commonly used for joint pain relief, may be linked to faster progression of Alzheimer's disease. The research, published in Nature Metabolism, indicates that individuals with mild cognitive impairment who take glucosamine are more likely to develop dementia compared to those who do not use the supplement. The study utilized a large analysis of patient health records and advanced imaging studies of human brain tissue and mouse models. Researchers found that glucosamine may interact with disrupted biological processes in the brain associated with Alzheimer's, potentially exacerbating the disease. The study highlights a specific protein and sugar-tagging pathway that is excessively active in Alzheimer's, suggesting a new target for future treatments.
Rapid Read Rapid Read
Hearing Loss and Tinnitus: Early Signs and Treatment Options Explored

Hearing Loss and Tinnitus: Early Signs and Treatment Options Explored

Hearing loss and tinnitus are common conditions affecting a significant portion of the U.S. population, particularly among older adults. According to the Centers for Disease Control and Prevention, about 13% of U.S. adults experience hearing difficulties, with the number rising to 27% among those aged 65 and older. Tinnitus, characterized by a persistent ringing or buzzing in the ears, affects around 10% of adults and is often associated with hearing loss. Dr. Jackie Price, an audiologist at Penn State Health, explains that tinnitus results from a communication problem between the ears and the brain, often due to damage in the cochlea. October is National Protect Your Hearing Month, and experts emphasize the importance of protecting hearing by limiting exposure to loud noises and using appropriate hearing protection. Treatment options for hearing loss and tinnitus include hearing aids and Tinnitus Retraining Therapy, which combines counseling and sound therapy to help manage symptoms.
Rapid Read Rapid Read
Psilocybin Shows Potential in Alzheimer's Treatment, Case Study Reveals

Psilocybin Shows Potential in Alzheimer's Treatment, Case Study Reveals

A recent case study published in Frontiers in Neuroscience highlights the potential of psilocybin, a compound found in magic mushrooms, in treating Alzheimer's disease. The study documents the case of an 80-year-old Japanese-American woman with severe Alzheimer's who experienced significant cognitive and motor improvements after taking a high dose of psilocybin. The woman, who had not spoken in five years, began talking and recalling autobiographical details 19 hours after the dose. The effects, including improved memory and motor control, lasted for several days. This case suggests that psilocybin may reactivate suppressed cognitive abilities in Alzheimer's patients.
Rapid Read Rapid Read
Psilocybin Treatment Shows Remarkable Effects on Alzheimer's Patient

Psilocybin Treatment Shows Remarkable Effects on Alzheimer's Patient

A recent case study published in Frontiers in Neuroscience highlights the effects of psilocybin, a compound found in magic mushrooms, on an elderly woman with Alzheimer's disease. The Japanese-American woman, in her 80s, had been suffering from severe symptoms of Alzheimer's for a decade, including an inability to speak coherently. After administering a high dose of psilocybin, the woman experienced a significant improvement in her cognitive and motor functions. She began speaking in full sentences, recalling autobiographical details, and showed improved physical abilities such as motor control and bladder function. These effects lasted for several weeks. A subsequent smaller dose also resulted in enhanced verbal expressivity and agility.
Rapid Read Rapid Read
New Weight Management System PATHWEIGH Shows Promise in Reducing Population Weight Gain

New Weight Management System PATHWEIGH Shows Promise in Reducing Population Weight Gain

A new weight management system called PATHWEIGH, developed by endocrinologist Leigh Perreault and her team, has shown promising results in reducing population-level weight gain. The program, supported by the National Institutes of Health, was implemented in 56 UCHealth primary care clinics across Colorado, reaching over 274,000 patients. Research published in Nature Medicine found that PATHWEIGH reduced population weight gain by 0.58 kg over 18 months and shifted the trend from weight gain to weight loss. The program increased the likelihood of patients receiving weight-related care by 23%, making it a potential model for standard obesity treatment.
Rapid Read Rapid Read
Northwestern Professor Removed from Conference for Distributing Anti-Trump Editorial

Northwestern Professor Removed from Conference for Distributing Anti-Trump Editorial

A Northwestern University professor, Justin Ryder, was escorted out of the American Diabetes Association's Scientific Sessions conference in New Orleans for distributing an editorial critical of President Trump's proposed budget cuts to the National Institutes of Health. The editorial, published in the journal Diabetes Care, criticized the administration's plan to cut $5 billion from the NIH's 2027 budget, which could impact research opportunities and patient care across the U.S. Ryder, along with four others, was removed by local law enforcement for violating conference policies on unauthorized material distribution. The American Diabetes Association emphasized that the removal was due to policy violations, not the editorial's content.
Rapid Read Rapid Read
University of Florida Research Links Glucosamine to Accelerated Alzheimer's Progression

University of Florida Research Links Glucosamine to Accelerated Alzheimer's Progression

Recent research from the University of Florida suggests that glucosamine, a supplement commonly used for joint pain relief, may be linked to faster progression of Alzheimer's disease. The study, published in Nature Metabolism, found that individuals with mild cognitive impairment who took glucosamine were more likely to develop dementia compared to those who did not use the supplement. The research involved analyzing patient health records and conducting advanced imaging studies on human brain tissue and mouse models. The findings indicate that glucosamine may interact with disrupted biological processes in the brain associated with Alzheimer's. Although the study does not establish causality, it highlights a potential metabolic dysfunction contributing to neurodegenerative diseases.
Reuters Reuters
Sidelined U.S. study on alcohol's health effects published in independent journal

Sidelined U.S. study on alcohol's health effects published in independent journal

By Emma Rumney LONDON, June 9 (Reuters) - A study that found even low levels of drinking alcohol can increase health risks was published in full on Tuesday in an independent journal after being sidelined by the Trump Administration, which opted not to consider the federally-commissioned research to
Trendline Trendline
Study Links Ultra-Processed Foods to Declines in Focus and Cognitive Health

Study Links Ultra-Processed Foods to Declines in Focus and Cognitive Health

Study Links Ultra-Processed Foods to Declines in Focus and Cognitive Health